Knotless Tissue Control Devices Market Snapshot (2022 to 2032)

Expanding at a CAGR of 3.4% from 2022 to 2032, the global knotless tissue control devices market is projected to secure a market value worth US$ 672.6 Million by 2032. In 2022, the market is projected at US$ 465.6 Million.

The growth of the market can be attributed to the increasing demand for minimally invasive procedures and growing technological advancement in the field.

Report Attributes Details
Projected Market Value (2022) US$ 465.6 Million
Anticipated Forecast Value (2032) US$ 672.6 Million
Estimated Growth Rate (2022 to 2032) 3.4%

Players in the market are focusing to develop their devices, which is projected to augment the market size in the forecast period. For instance, Ethicon announced the launch of STRATAFIX Spiral PDS Plus and STRATAFIX Spiral Monocryl Plus Knotless Tissue Control Devices. With the development of these two new suture technologies to the STRATAFIX Family of Knotless Tissue Control Devices, Ethicon has produced the most comprehensive knotless suture for surgeons in the USA Such factors are expected to benefit the market in the coming time.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Factors Propelling the Global Knotless Tissue Control Devices Market?

Benefits offered by knotless tissue control devices such as offering distribution of tension along the wound, simplified knot tying, and reduced knot-related complications, are expected to boost its demand in healthcare infrastructures.

An increasing number of surgical procedures is anticipated to benefit the market in the assessment period. Growing cases of knee replacements, bypass surgeries, hip replacements, and cosmetic surgeries are likely to drive the industry in the coming years. According to a study published by the National Centre for Biotechnology Information, there are about 30% of aged people fall because of difficulty in walking, which is the primary cause of knee replacement surgeries.

The launch of efficient devices by players in the market is expected to strengthen the industry. In September 2020, Smith & Nephew launched HELICOIL knotless sutures that function through the bone marrow and associated stem cells that boost the healing process.

What are the Factors Hampering the Global Knotless Tissue Control Devices Market?

The availability of alternate wound healing products is projected to hamper the market growth in the forecast period. Other limitations include surgical site infection, high-cost antibacterial equipment, and cross-hatched marks. Further, the lack of reimbursement policies for wound management in developing countries is anticipated to inhibit market growth in the forthcoming time.

However, the introduction of advanced products is likely to act as a significant counter to hampering causes and thus, propelling the market growth. In April 2021, Dolphin Sutures announced the launch of a non-absorbable polytetrafluorethylene (PTFE) suture.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America Expected to Dominate the Global Knotless Tissue Control Devices Market?

As per the analysis, the global knotless tissue control devices market is expected to be dominated by North America during the forecast period. In 2022, the region is estimated to garner 42.6% of the global market share.

The domination of the region can be attributed to the increasing prevalence of chronic illness, which has resulted in increased demand for surgical sutures. Also, presence of leading players in the USA like Ethicon US LLC, are focusing on technologically innovating their devices.

What is the Role of Europe in Developing the Global Knotless Tissue Control Devices Market?

According to the analysis, Europe is expected to be the second-largest market for knotless tissue control devices. In 2022, the region is anticipated to secure about 28.5% of the global market share.

The growth of the market can be attributed to the developed healthcare infrastructure in the UK, Germany, and the introduction of developed suturing equipment by Smith and Nephew. As per National Joint Registry, about 160,000 hip and knee replacement surgeries are performed annually in Wales and England.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Why is Asia-Pacific Projected to be the Most Lucrative Market for Knotless Tissue Control Devices?

According to the analysis, Asia-Pacific is anticipated to be the most lucrative market for knotless tissue control devices during the forecast period.

The growth of the market can be attributed to the increasing prevalence of gynecological and cardiovascular diseases accelerating the number of surgeries and procedures. Also, increasing awareness of advanced surgical devices and the growing focus of players to gain a competitive edge in developing countries of the region are expected to support the market growth. According to an analysis, about 1,453 surgical procedures are performed every year per 100,000 population in India.

What is the Role of Startups in Developing the Knotless Tissue Control Devices Market?

Dalent Medical, OTTek, Fasciotens, Edge Surgical, Medical Micro instruments, Imbed Biosciences, Grapheal, Axio, Guard Medical, Gecko, Adhesys Medical, Kerecis, and Acera Surgical are some of the emerging entities in the global knotless tissue control devices market.

Emerging entities are making a significant contribution to the market. For instance, Acera Surgical offers synthetic electrospun scaffolds for regenerative medical applications. The company develops products that include a pliable, soft, white, porous polymer matrix, another to be used with tensionless sutures, and a soft, non-friable, absorbable matrix that acts as a protective covering for wound defects. The company received FDA clearance for its products. Thus, startups are likely to make a significant contribution to developing the market in the forecast period.

Competition Analysis

Key players in the global knotless tissue control devices market include Johnson & Johnson Services, Inc., Medtronic, and Ethicon US, LLC. (Subsidiary of Johnson & Johnson), and Medline Industries, Inc.

  • In July 2022, Medtronic, a known leader in healthcare technology, announced it has inked an agreement with CathWorks, a company headquartered in Kefar Sava, Israel, which focuses to transform how coronary artery disease (CAD) is diagnosed and treated.
  • In June 2021, Blackstone, Carlyle, and Hellman & Friedman announced to acquisition of Northfield, Ill-based Medline for US$ 30 Billion. Medline is the largest privately held manufacturer and distributor of healthcare supplies.

Report Scope

Report Attribute Details
Growth Rate (2022 to 2032) 3.4%
Market Value in 2022 US$ 465.6 Million
Market Value in 2032 US$ 672.6 Million
Base Year for Estimation 2021
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units USD Million for Value
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product Type
  • End User
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Countries Profiled
  • United States of America
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Poland
  • Russia
  • Australia & New Zealand
  • China
  • India
  • ASIAN
  • GCC Countries
  • North Africa
  • South Africa
Key Companies Profiled
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Ethicon US, LLC. (Subsidiary of Johnson & Johnson)
  • Medline Industries, Inc.
Customization Scope Available upon Request

Key Segments Profiled in the Global Knotless Tissue Control Devices Market

By Product Type:

  • Short-Term
  • Long-Term
  • Nonabsorbable Polymers

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research Centers and Laboratory

By Region:

  • North American
  • Latin American
  • Western European
  • Eastern European
  • Asia-Pacific
  • Japanese
  • Middle East and Africa

Frequently Asked Questions

What is the Expected Market Value of the Global Knotless Tissue Control Devices Market during the forecast period?

The global knotless tissue control devices market is expected to secure US$ 672.6 Million by 2032.

What is the Projected CAGR of the Global Knotless Tissue Control Devices Market in the Assessment Period?

The global knotless tissue control devices market is projected to display a CAGR of 3.4% during the forecast period.

Which are the Eminent Players in the Global Knotless Tissue Control Devices Market?

Johnson & Johnson Services, Inc., and Medtronic, are some of the eminent players in the global knotless tissue control devices market.

Table of Content
1. Executive Summary | Knotless Tissue Control Devices Market
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2016 to 2021 and Forecast, 2022 to 2032
    4.1. Historical Market Size Value (US$ Million) Analysis, 2016 to 2021
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Product Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2016 to 2021
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
        5.3.1. Short-Term
        5.3.2. Long-Term
        5.3.3. Nonabsorbable Polymers
    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2016 to 2021
    5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2016 to 2021
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
        6.3.1. Hospitals
        6.3.2. Ambulatory Surgical Centers
        6.3.3. Trauma Centers
        6.3.4. Medical Device Manufacturers
        6.3.5. Pharmaceutical Companies
        6.3.6. Research Centers and Laboratory
    6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021
    6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2016 to 2021
    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Europe
        7.3.4. Asia Pacific
        7.3.5. Middle East and Africa
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
        8.2.1. By Country
            8.2.1.1. United States of America
            8.2.1.2. Canada
        8.2.2. By Product Type
        8.2.3. By End User
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Product Type
        8.3.3. By End User
    8.4. Key Takeaways
9. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Product Type
        9.2.3. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product Type
        9.3.3. By End User
    9.4. Key Takeaways
10. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. United Kingdom
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Europe
        10.2.2. By Product Type
        10.2.3. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product Type
        10.3.3. By End User
    10.4. Key Takeaways
11. Asia Pacific Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
        11.2.1. By Country
            11.2.1.1. China
            11.2.1.2. Japan
            11.2.1.3. South Korea
            11.2.1.4. India
            11.2.1.5. Malaysia
            11.2.1.6. Singapore
            11.2.1.7. Australia
            11.2.1.8. New Zealand
            11.2.1.9. Rest of Asia-Pacific (APAC)
        11.2.2. By Product Type
        11.2.3. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product Type
        11.3.3. By End User
    11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2016 to 2021
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
        12.2.1. By Country
            12.2.1.1. GCC Countries
            12.2.1.2. South Africa
            12.2.1.3. Israel
            12.2.1.4. Rest of Middle East and Africa
        12.2.2. By Product Type
        12.2.3. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product Type
        12.3.3. By End User
    12.4. Key Takeaways
13. Key Countries Market Analysis
    13.1. United States of America
        13.1.1. Pricing Analysis
        13.1.2. Market Share Analysis, 2021
            13.1.2.1. By Product Type
            13.1.2.2. By End User
    13.2. Canada
        13.2.1. Pricing Analysis
        13.2.2. Market Share Analysis, 2021
            13.2.2.1. By Product Type
            13.2.2.2. By End User
    13.3. Brazil
        13.3.1. Pricing Analysis
        13.3.2. Market Share Analysis, 2021
            13.3.2.1. By Product Type
            13.3.2.2. By End User
    13.4. Mexico
        13.4.1. Pricing Analysis
        13.4.2. Market Share Analysis, 2021
            13.4.2.1. By Product Type
            13.4.2.2. By End User
    13.5. Germany
        13.5.1. Pricing Analysis
        13.5.2. Market Share Analysis, 2021
            13.5.2.1. By Product Type
            13.5.2.2. By End User
    13.6. United Kingdom
        13.6.1. Pricing Analysis
        13.6.2. Market Share Analysis, 2021
            13.6.2.1. By Product Type
            13.6.2.2. By End User
    13.7. France
        13.7.1. Pricing Analysis
        13.7.2. Market Share Analysis, 2021
            13.7.2.1. By Product Type
            13.7.2.2. By End User
    13.8. Spain
        13.8.1. Pricing Analysis
        13.8.2. Market Share Analysis, 2021
            13.8.2.1. By Product Type
            13.8.2.2. By End User
    13.9. Italy
        13.9.1. Pricing Analysis
        13.9.2. Market Share Analysis, 2021
            13.9.2.1. By Product Type
            13.9.2.2. By End User
    13.10. China
        13.10.1. Pricing Analysis
        13.10.2. Market Share Analysis, 2021
            13.10.2.1. By Product Type
            13.10.2.2. By End User
    13.11. Japan
        13.11.1. Pricing Analysis
        13.11.2. Market Share Analysis, 2021
            13.11.2.1. By Product Type
            13.11.2.2. By End User
    13.12. South Korea
        13.12.1. Pricing Analysis
        13.12.2. Market Share Analysis, 2021
            13.12.2.1. By Product Type
            13.12.2.2. By End User
    13.13. Malaysia
        13.13.1. Pricing Analysis
        13.13.2. Market Share Analysis, 2021
            13.13.2.1. By Product Type
            13.13.2.2. By End User
    13.14. Singapore
        13.14.1. Pricing Analysis
        13.14.2. Market Share Analysis, 2021
            13.14.2.1. By Product Type
            13.14.2.2. By End User
    13.15. Australia
        13.15.1. Pricing Analysis
        13.15.2. Market Share Analysis, 2021
            13.15.2.1. By Product Type
            13.15.2.2. By End User
    13.16. New Zealand
        13.16.1. Pricing Analysis
        13.16.2. Market Share Analysis, 2021
            13.16.2.1. By Product Type
            13.16.2.2. By End User
    13.17. GCC Countries
        13.17.1. Pricing Analysis
        13.17.2. Market Share Analysis, 2021
            13.17.2.1. By Product Type
            13.17.2.2. By End User
    13.18. South Africa
        13.18.1. Pricing Analysis
        13.18.2. Market Share Analysis, 2021
            13.18.2.1. By Product Type
            13.18.2.2. By End User
    13.19. Israel
        13.19.1. Pricing Analysis
        13.19.2. Market Share Analysis, 2021
            13.19.2.1. By Product Type
            13.19.2.2. By End User
14. Market Structure Analysis
    14.1. Competition Dashboard
    14.2. Competition Benchmarking
    14.3. Market Share Analysis of Top Players
        14.3.1. By Regional
        14.3.2. By Product Type
        14.3.3. By End User
15. Competition Analysis
    15.1. Competition Deep Dive
        15.1.1. Medtronic
            15.1.1.1. Overview
            15.1.1.2. Product Portfolio
            15.1.1.3. Profitability by Market Segments
            15.1.1.4. Sales Footprint
            15.1.1.5. Strategy Overview
                15.1.1.5.1. Marketing Strategy
        15.1.2. Johnson & Johnson Services, Inc.
            15.1.2.1. Overview
            15.1.2.2. Product Portfolio
            15.1.2.3. Profitability by Market Segments
            15.1.2.4. Sales Footprint
            15.1.2.5. Strategy Overview
                15.1.2.5.1. Marketing Strategy
        15.1.3. Ethicon US, LLC.
            15.1.3.1. Overview
            15.1.3.2. Product Portfolio
            15.1.3.3. Profitability by Market Segments
            15.1.3.4. Sales Footprint
            15.1.3.5. Strategy Overview
                15.1.3.5.1. Marketing Strategy
        15.1.4. Medline Industries, Inc.
            15.1.4.1. Overview
            15.1.4.2. Product Portfolio
            15.1.4.3. Profitability by Market Segments
            15.1.4.4. Sales Footprint
            15.1.4.5. Strategy Overview
                15.1.4.5.1. Marketing Strategy
        15.1.5. Royal Dutch Shell Plc.
            15.1.5.1. Overview
            15.1.5.2. Product Portfolio
            15.1.5.3. Profitability by Market Segments
            15.1.5.4. Sales Footprint
            15.1.5.5. Strategy Overview
                15.1.5.5.1. Marketing Strategy
        15.1.6. ExxonMobil Corporation
            15.1.6.1. Overview
            15.1.6.2. Product Portfolio
            15.1.6.3. Profitability by Market Segments
            15.1.6.4. Sales Footprint
            15.1.6.5. Strategy Overview
                15.1.6.5.1. Marketing Strategy
        15.1.7. PetroChina Company Limited
            15.1.7.1. Overview
            15.1.7.2. Product Portfolio
            15.1.7.3. Profitability by Market Segments
            15.1.7.4. Sales Footprint
            15.1.7.5. Strategy Overview
                15.1.7.5.1. Marketing Strategy
        15.1.8. BP P.L.C.
            15.1.8.1. Overview
            15.1.8.2. Product Portfolio
            15.1.8.3. Profitability by Market Segments
            15.1.8.4. Sales Footprint
            15.1.8.5. Strategy Overview
                15.1.8.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Recommendations

Healthcare

Tissue Sealants and Tissue Adhesive Market

June 2022

REP-GB-862

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Knotless Tissue Control Devices Market

Schedule a Call